The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Ebrahim Homani - CM-CIC Securities - Analyst
: Hello Alessandro. Hello STbastien. Thank you for taking my question. I have, if I may, the first one is about the ADA, given the EBITDA, [21%] you
confirm that, maintaining the margin at the 16% as it was in 2024 would be maybe difficult. My second question is about your organic growth.
Could you please give us more details on volume and prices?
And did you outperform your coms in terms of volume and gain market shares? And my last question is about TQC and its contribution. It was in
Q1, it is the same contribution, sorry, than it was in Q3 and far below than in Q4. Is there any Trump impact and what to expect in in the next
quarters?
Thank you.
Question: Ebrahim Homani - CM-CIC Securities - Analyst
: Thank you very much for the answer.
Question: Sven Edelfelt - ODDO BHF - Analyst
: Yes, thank you. Good afternoon and congratulations for the results. I had three questions if I may. The first one is on, can you comment on what's
going on with the Imerys Italy which has been included within the agreement on that? Second question regarding the integration would be about
the agenda.
It seems that there is a new hearing that is scheduled on June 26. I just wanted to better understand what this hearing about and does that mean
that the confirmation hearing is now over? So that's the first question. Sorry, it's a bit of a long question. The second question would be, do you
want to answer this one or shall I continue to ask?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
APRIL 28, 2025 / 4:30PM, IMTP.PA - Q1 2025 Imerys SA Earnings Call
Question: Sven Edelfelt - ODDO BHF - Analyst
: Okay. The second question, I don't really understand the volume trend actually. I appreciate you mentioned your competitor being down at 5%
on the -- you're basically gaining a market share. But what I don't understand is when looking at the base of comparison I mean, last year Q1 was
the worst quarter of the year. It was down volume wise 3.4% with the rest of the quarter being up 2% to 4%, in volume. So that's some -- that's the
part that I'm missing here. Does that mean that Q1 25, there is a cliff and something went wrong on the market? So that's the second question.
And the third one would be about the full year I know you don't provide guidance, but I mean, are you still on track to make the EUR650 million of
EBITDA for the year that the consensus is targeting? Maybe you can give a little bit of flavor on that.
That's the three question with the one being (inaudible).
Question: Sven Edelfelt - ODDO BHF - Analyst
: So 60% is still possible then. Thank you very much.
Question: Aron Ceccarelli - Berenberg - Analyst
: Hello, good evening. Thanks for taking my question and congratulations on the good results. I have a question on carbon black and synthetic
graphite and very strong rebound continuing.
Maybe can you provide some color around the split of the growth here between volumes and pricing and also I would like to understand, I know
that you know your product is better than compared to this one here. I'd like to understand how do you think about the potential profitability
going forward once you know the volume continued to come and we saw around 24% before the stocking. So I would like to understand, how
you think about normalizing margins here?
And the second question is around current trading. I would like to understand if you can provide any color around business environment in April?
I understand you said March was the best month. I would like to understand about April if that's possible? Any comment would be useful. Thank
you.
Question: Aron Ceccarelli - Berenberg - Analyst
: Thank you. All the best.
| 
